Pasar al contenido principal

INTERACTOMAS DEL NODO GRK2 EN SEÑALIZACION CELULAR E IMPLICACIONES PATOLOGICAS

PID2023-146735OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Loss of Gαq reshapes fibroblast traits and drives tumor-stroma remodeling in oral cancer progression

  • Navarro-Lérida, Inmaculada
  • Huertas-Lárez, Raquel
  • Paredes-García, Gemma
  • García-Mateos, Dafne
  • Jiménez-López, María Isabel
  • Prieto-Fernández, Llara
  • Pascual, Ania
  • Ávila-Oca, Virginia
  • López, Juan Antonio
  • Pozo, Miguel Ángel del
  • Álvarez-Teijeiro, Saúl
  • García-Pedrero, Juana María
  • García-Escudero, Ramón
  • Mayor, Federico
  • Ribas, Catalina
Head and neck squamous cell carcinoma is an aggressive malignancy with limited therapeutic options and poor outcomes. A key driver of tumor progression is the tumor microenvironment, particularly cancer-associated fibroblasts, which remodel the extracellular matrix and secrete pro-tumorigenic signals. Emerging evidence suggests that vesicle trafficking pathways regulate these secretory functions, though their role in HNSCC remains unclear. Building on our discovery of Gαq as an autophagy regulator, we investigated how its absence reshapes fibroblast behavior and modulates crosstalk with HNSCC cells. We demonstrate that loss of Gαq reprograms murine fibroblasts into a CAF-like phenotype through deregulated intracellular trafficking and increased ceramide accumulation. Gαq-deficient fibroblasts show increased collagen I deposition, ECM remodeling, and secretion. Their exosomes, enriched in tumor-promoting growth factor receptors, suppress Caveolin-1 in tumor cells and induce an EMT-like phenotype that fuels HNSCC growth. In co-culture and in vivo, Gαq-silenced fibroblasts form "railroad-track" structures guiding cancer cell migration and invasion. Reduced Gαq expression in human fibroblasts recapitulates these features, identifying Gαq as a key regulator of fibroblast plasticity and tumor-stroma interactions in HNSCC progression., We want to acknowledge the Principado de Asturias BioBank (PT23/00077), financed jointly by Servicio de Salud del Principado de Asturias, Instituto de Salud Carlos III and Fundacion Bancaria Cajastur, and integrated in the Spanish National Biobanks Network. This work was supported by Instituto de Salud Carlos III (grants PI22_00966 and PI25_01456 to CR, PI22_00167 to JMG-P, PI24_00398 to SA-T, and PI21_00208 to RG-E, co-funded with European FEDER contribution), Agencia Estatal de Investigación of Spain (grant PID2023-146735OB-I00 to FM), H2020-MSCA Program, Grant agreement 860229-ONCORNET 2.0 to FM), CIBERCV-Instituto de Salud Carlos III, Spain (grant CB16/11/00278 to FM, co-funded with European FEDER contribution), Fundación Ramón Areces grants (to FM and CR), Programa de Actividades en Biomedicina de la Comunidad de Madrid-S2022/BMD-7209-INTEGRAMUNE (to FM). CIBERONC-Instituto de Salud Carlos III (CB16/12/00390 to JMG-P, and CB16/12/00228 to RG-E, co-funded with European FEDER contribution). LP-F and RH-L are recipients of a FPU predoctoral fellowship from the Spanish Ministry of Education (FPU20/01588 and FPU22/00979, respectively), and SA-T is a recipient of a Miguel Servet research contract from ISCIII (CP23/00101) and co-funded with European FEDER contribution. AP (PEJ-2023-TL-SAL-GL-26867), and VA-O (PEJ-2024-AI-SAL-GL-33271) were supported by a European Social Fund Plus (ESF + ) co-funded grant from Comunidad Autonoma de Madrid. We also acknowledge institutional support for the CBM from Fundación Ramón Areces. The CBM is a Severo Ochoa Center of Excellence (grant CEX2021-001154-S), funded by the Spanish Agencia Estatal de Investigación. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia, Innovación Universidades (MCIU) and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIU/AEI/10.13039/501100011033)., Peer reviewed